当前位置 首页 科研队伍

郑州大学联合实验室

薛白  助理研究员  

郑州大学 基础医学院
纳米酶医学研究中心

研究方向:纳米酶生物医学应用研究

电子邮件:xuebai2022@zzu.edu.cn

电       话:

通讯地址:河南省郑州市科学大道100号郑州大学新校区

英文版个人网页:

简       历:

  2012 - 2016  重庆医科大学 获学士学位

  2016 - 2022  电子科技大学 获博士学位

  2022 - 至今  郑州大学 助理研究员

获奖及荣誉:

社会任职:

 

研究方向:

  (1)纳米酶设计与构建及其生物医学应用

  (2)致盲眼病纳米酶抗氧化治疗研究

承担项目情况:

代表论著:

  1. Bai Xue; Mengyue Ge; Kelong Fan; Xinglu Huang; Xiyun Yan; Wei Jiang; Bing Jiang; Zhenglin Yang; Mitochondria-targeted nanozymes eliminate oxidative damage in retinal neovascularization disease, Journal of Controlled Release, 2022, 350: 271-283.

  2. Ruofei Zhang#; Bai Xue#; Yanhong Tao#; Hanqing Zhao; Zixia Zhang; Xiaonan Wang; Xinyao Zhou; Bing Jiang; Zhenglin Yang; Xiyun Yan; Kelong Fan ; Edge‐Site Engineering of Defective Fe–N 4 Nanozymes with Boosted Catalase‐Like Performance for Retinal Vasculopathies, Advanced Materials, 2022, 34(39): 2270275.

  3. Bai Xue; Ping Wang; Wenzhen Yu; Jing Feng; Jie Li; Rulian Zhao; Zhenglin Yang; Xiyun Yan; Hongxia Duan; CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseases, Science China Life Sciences, 2021, 65(6): 1157-1170.

  4. Bai Xue; Shanshan Zhang; Li Gan; Weifeng Lu; Jie Li; A new hand-held holder optimizes the parameters of the laser-induced choroidal neovascularization model in mice, Experimental Eye Research, 2021, 203: 108392.

  5. Jialiang Yang; Yuhong Chen; Tongdan Zou; Bai Xue; Fang Yang; Xiangzhou Wang; Yibo Huo; Boyun Yan; Yuxia Xu; Shiyu He; Yi Yin; Jing Wang; Xiong Zhu; Lin Zhang; Yu Zhou; Zhengfu Tai; Ping Shuai; Man Yu; Qian Luo; Yilian Cheng; Bo Gong; Xianjun Zhu; Jing Zhang; Xinghuai Sun; YingLin; Houbin Zhang; Zhenglin Yang ; Cholesterol homeostasis regulated by ABCA1 is critical for retinal ganglion cell survival, Science China Life Sciences, 2022, 66(2): 211-225.